13F-HR filed by RP Management, LLC
RP Management, LLC filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-12, with 6 holding rows worth $667,251,000.
- Accession
- 0001507673-20-000013
- Filer
- CIK 1507673
- Filed
- 2020-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 6 entries on the cover page, a total value of $667,251,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $667,251,000 with VALUE read as thousands by filing date, 13F file number 028-19261. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerLegorreta Pablo G.028-19630
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOMEDICS INC | 452907108 | COM | 4,373,178 | $371,851,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 2,111,111 | $137,243,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 9,166,667 | $109,358,000 | thousands by filing date | |
| EPIZYME INC | 29428V904 | COM | 2,500,000 | $29,825,000 | thousands by filing date | call |
| CYTOKINETICS INC | 23282W605 | COM NEW | 875,656 | $18,958,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 129,517 | $16,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001507673-20-000013 | this filing | 2020-11-12 | acceptance time not in the bulk data set |